During the past decade, Pitt CRS conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 3 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Pitt CRS" #1 collaborator was "Glaxo Wellcome" with 3 trials as a collaborator, "Merck Sharp & Dohme LLC" with 2 trials as a collaborator, "Microbicide Trials Network" with 2 trials as a collaborator, "National Institute of Allergy and Infectious Diseases (NIAID)" with 2 trials as a collaborator and "AIDS Clinical Trials Group" with 1 trials as a collaborator. Other collaborators include 7 different institutions and companies that were collaborators in the rest 17 trials.

According to Clinical.Site data, the most researched conditions in "Pitt CRS" are "HIV Infections" (30 trials), "HIV Infection" (2 trials), "Histoplasmosis" (2 trials), "Pneumonia, Pneumocystis Carinii" (2 trials) and "Sarcoma, Kaposi" (2 trials). Many other conditions were trialed in "Pitt CRS" in a lesser frequency.

Most popular intervention types in "Pitt CRS" are "Drug" (30 trials), "Biological" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Zidovudine" (7 trials), "Atazanavir" (3 trials), "Itraconazole" (3 trials), "Leucovorin calcium" (3 trials) and "Ritonavir" (3 trials). Other intervention names were less common.

The vast majority of trials in "Pitt CRS" are 28 trials for "All" genders, 3 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Pitt CRS". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 32 completed trials in Pitt CRS, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Pitt CRS, 5 "Phase 1" clinical trials were conducted, 13 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 3 trials that are defined as “Not Applicable".